Annexin A1 Is increased in the plasma of preeclamptic women

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Perucci, Luiza O ^a   Carneiro, Fernanda S ^a   Ferreira, Cláudia N ^a   Sugimoto, Michelle A ^a   Soriani, Frederico M ^a   Martins, Gustavo G ^b   Lima, Kátia M ^a   Guimarães, Flávia L ^a   Teixeira, Antônio L ^a   Dusse, Luci M ^a   Gomes, Karina B ^a   Sousa, Lirlândia P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Hospital Municipal Odilon Behrens   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LIPOCORTIN 1; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR 1; TNFRSF1A PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD PRESSURE; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GESTATIONAL AGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREECLAMPSIA; PREGNANCY; PROTEIN BLOOD LEVEL; TURBIDIMETRY; BLOOD; GENETICS; METABOLISM; YOUNG ADULT;

ADULT; ANNEXIN A1; C-REACTIVE PROTEIN; FEMALE; GESTATIONAL AGE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; YOUNG ADULT;

EID: 84946925873     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138475     Document Type: Article

References (36)

1. Gynecologists ACoOa, Pregnancy TFoHi. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122(5):1122-31. doi: 10.1097/01.AOG.0000437382.03963.88 PMID: 24150027.
2. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009; 33(3):130-7. doi: 10.1053/j.semperi.2009.02.010 PMID: 19464502.
3. Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 1995; 173(4):1042-8. PMID: 7485291.
4. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014; 10(8):466-80. doi: 10.1038/nrneph.2014.102 PMID: 25003615.
5. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999; 180(2 Pt 1):499-506. PMID: 9988826.
6. Lau SY, Guild SJ, Barrett CJ, Chen Q, McCowan L, Jordan V, et al. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol. 2013; 70(5):412-27. doi: 10.1111/aji.12138 PMID: 23790133.
7. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998; 179(1):80-6. PMID: 9704769.
8. Luppi P, Tse H, Lain KY, Markovic N, Piganelli JD, DeLoia JA. Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol. 2006; 56(2):135-44. doi: 10.1111/j.1600-0897.2006.00386.x PMID: 16836616.
9. Saito S. Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. Immunol Cell Biol. 2010; 88(6):615-7. doi: 10.1038/icb.2010.68 PMID: 20498674.
10. Farzadnia M, Ayatollahi H, Hasan-Zade M, Rahimi HR. A comparative study of vascular cell adhesion molecule-1 and high-sensitive C-reactive protein in normal and preeclamptic pregnancies. Interv Med Appl Sci. 2013; 5(1):26-30. doi: 10.1556/IMAS.5.2013.1.5 PMID: 24265885; PubMed Central PMCID: PMCPMC3831793.
11. Flower RJ. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol. 1988; 94(4):987-1015. PMID: 2974738; PubMed Central PMCID: PMCPMC1854095.
12. Flower RJ, Rothwell NJ. Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci. 1994; 15(3):71-6. PMID: 8184489.
13. Parente L, Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm Res. 2004; 53 (4):125-32. doi: 10.1007/s00011-003-1235-z PMID: 15060718.
14. Vago JP, Nogueira CR, Tavares LP, Soriani FM, Lopes F, Russo RC, et al. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol. 2012; 92(2):249-58. doi: 10.1189/jlb.0112008 PMID: 22493082.
15. Solito E, de Coupade C, Parente L, Flower RJ, Russo-Marie F. IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine. 1998; 10(7):514-21. doi: 10.1006/cyto.1997.0325 PMID: 9702415.
16. Perucci LO, Gomes KB, Freitas LG, Godoi LC, Alpoim PN, Pinheiro MB, et al. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLoS One. 2014; 9(5):e97632. doi: 10.1371/journal.pone.0097632 PMID: 24851923; PubMed Central PMCID: PMCPMC4031102.
17. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol. 1995; 54(1):1-8. PMID: 7859870.
18. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000; 894:i-xii, 1-253. PMID: 11234459.
19. Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006; 11(5):309-16. doi: 10.1016/j.siny.2006.04.001 PMID: 16828580.
20. Hall DR, Odendaal HJ, Kirsten GF, Smith J, Grové D. Expectant management of early onset, severe pre-eclampsia: perinatal outcome. BJOG. 2000; 107(10):1258-64. PMID: 11028578.
21. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001; 97(4):533-8. PMID: 11275024.
22. Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 2009; 9(1):62-70. doi: 10.1038/nri2470 PMID: 19104500.
23. Sousa LP, Alessandri AL, Pinho V, Teixeira MM. Pharmacological strategies to resolve acute inflammation. Curr Opin Pharmacol. 2013; 13(4):625-31. doi: 10.1016/j.coph.2013.03.007 PMID: 23578762.
24. Borges VT, Peraçoli JC, Romão M, Zanati S, Poiati JR, Weel IC, et al. Differentiation between early and late pre-eclampsia by inflammatory cytokines and the association between IL-1β and left cardiac hypertrophy. Pregnancy Hypertension. 2015; 5:53-156.
25. Zhang Z, Gao Y, Zhang L, Jia L, Wang P, Zhang L, et al. Alterations of IL-6, IL-6R and gp130 in early and late onset severe preeclampsia. Hypertens Pregnancy. 2013; 32(3):270-280. doi: 10.3109/10641955.2013.798332 PMID: 23782174.
26. Leoni G, Neumann PA, Kamaly N, Quiros M, Nishio H, Jones HR, et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J Clin Invest. 2015; 125 (3):1215-27. doi: 10.1172/JCI76693 PMID: 25664854.
27. Wang X, Zhu M, Hjorth E, Cortés-Toro V, Eyjolfsdottir H, Graff C, et al. Resolution of inflammation is altered in Alzheimer's disease. Alzheimers Dement. 2015; 11(1):40-50.e1-2. doi: 10.1016/j.jalz.2013.12.024 PMID: 24530025; PubMed Central PMCID: PMCPMC4275415.
28. Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev. 2006; 58(3):463-87. doi: 10.1124/pr.58.3.4 PMID: 16968948.
29. Cooray SN, Gobbetti T, Montero-Melendez T, McArthur S, Thompson D, Clark AJ, et al. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc Natl Acad Sci U S A. 2013; 110(45):18232-7. doi: 10.1073/pnas.1308253110 PMID: 24108355; PubMed Central PMCID: PMCPMC3831442.
30. Planagumà A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med. 2008; 178(6):574-82. doi: 10.1164/rccm.200801-061OC PMID: 18583575; PubMed Central PMCID: PMCPMC2542432.
31. Simiele F, Recchiuti A, Mattoscio D, De Luca A, Cianci E, Franchi S, et al. Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity. FASEB J. 2012; 26(3):1323-33. doi: 10.1096/fj.11-198069 PMID: 22131270.
32. Vong L, Ferraz JG, Dufton N, Panaccione R, Beck PL, Sherman PM, et al. Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS One. 2012; 7(6):e39244. doi: 10.1371/journal.pone.0039244 PMID: 22723974; PubMed Central PMCID: PMCPMC3377644.
33. Tsai WH, Li IT, Yu YB, Hsu HC, Shih CH. Serial changes in plasma annexin A1 and cortisol levels in sepsis patients. Chin J Physiol. 2014; 57(1):1-7. doi: 10.4077/CJP.2014.BAB193 PMID: 24621333.
34. Särndahl E, Bergström I, Nijm J, Forslund T, Perretti M, Jonasson L. Enhanced neutrophil expression of annexin-1 in coronary artery disease. Metabolism. 2010; 59(3):433-40. doi: 10.1016/j.metabol.2009.07.044 PMID: 19850308.
35. D'Acquisto F, Perretti M, Flower RJ. Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol. 2008; 155(2):152-69. doi: 10.1038/bjp.2008.252 PMID: 18641677; PubMed Central PMCID: PMCPMC2538690.
36. Sun M, Liu Y, Gibb W. Distribution of annexin I and II in term human fetal membranes, decidua and placenta. Placenta. 1996; 17(2-3):181-4. PMID: 8730889.